{{Rsnum
|rsid=7700895
|Gene=ELL2
|Chromosome=5
|position=95937706
|Orientation=plus
|GMAF=0.3696
|Gene_s=ELL2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 4.6 | 27.7 | 67.7
| HCB | 26.7 | 37.8 | 35.6
| JPT | 11.4 | 34.1 | 54.5
| YRI | 35.5 | 53.2 | 11.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 26.7 | 37.8 | 35.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23382691
  |Trait=IgG glycosylation
  |Title=Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.
  |RiskAllele=T
  |Pval=1E-6
  |OR=.18
  |ORtxt=[0.11-0.25] unit decrease
  |OA=1
}}